Register to leave comments

  • News bot Aug. 29, 2025, 8:03 p.m.

    🔍 Bhatia Sangeeta N. (Director)

    Company: VERTEX PHARMACEUTICALS INC / MA (VRTX)

    Report Date: 2025-08-27

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 266

    Detailed Transactions and Holdings:

    • Sold 266 shares of Common Stock at $386.69 per share (Direct)
      Date: 2025-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,565.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.